Amgen Company IP News and Updates

The recent judgment in Amgen v Sanofi by the United States Supreme Court has generated significant attention within the legal...

Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought...

In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed...

CASE OF THE WEEK Amgen Inc. v. Amneal Pharmaceuticals LLC, et al., Appeal Nos. 2018-2414, et al. (Fed. Cir. Jan....

Amgen, Inc. v. Amneal Pharmas. LLC et al Before Newman, Lourie, and Taranto.  Appeal from the U.S. District Court for...

PTAB 2019: A Year of New Precedent There were a number of high profile developments at the Patent Trial &...

CASE OF THE WEEK Blackbird Tech LLC v. Health in Motion LLC, Appeal No. 2018-2393 (Fed. Cir. Dec. 16, 2019)...

AMGEN INC. v. HOSPIRA, INC. Before Moore, Bryson, and Chen.  Appeal from the United States District Court for the District...

CASE OF THE WEEK Celgene Corporation v. Laura A. Peter, Appeal Nos. 2018-1167, -1168, -1169, -1171 (Fed. Cir. July 30,...

CASE OF THE WEEK Amgen Inc. v. Sandoz Inc., Appeal No. 2018-1551 (Fed. Cir. May 8, 2019) In an appeal...